Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2018

06.02.2018 | Original Article

Stool PCR for Gastrointestinal Pathogens in Patients With and Without Immune-Mediated Intestinal Diseases

verfasst von: Yael R. Nobel, Jordan Axelrad, Suzanne K. Lewis, Susan Whittier, Garrett Lawlor, Simon Lichtiger, Peter H. R. Green, Benjamin Lebwohl

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with celiac disease and inflammatory bowel disease, two immune-mediated luminal conditions, have higher rates of certain infections than healthy counterparts. The prevalence of many gastrointestinal infections in these patients, however, is unknown.

Aims

Using a novel clinical stool pathogen PCR test, we investigated the hypothesis that patients with celiac disease/inflammatory bowel disease had different distributions of diarrheal pathogens than other patients.

Methods

We performed a retrospective cohort study of outpatients who underwent stool pathogen testing with the FilmArray Gastrointestinal PCR Panel (BioFire Diagnostics, Salt Lake City, UT) at our institution from January 1 to December 31, 2015. Rates of pathogens were measured in patients with or without celiac disease/inflammatory bowel disease.

Results

Of 955 patients, 337 had positive test for any pathogen, with 465 bacterial, parasitic, or viral pathogens identified. One hundred and twenty-seven patients (13.3%) had celiac disease or inflammatory bowel disease, of which 29/127 (22.8%) had a positive test, compared to 308/828 other patients (37.2%) (p = 0.002). Patients with celiac disease/inflammatory bowel disease had significantly fewer viruses (1.6 vs. 8.1% of patients; p = 0.008) and parasites (0 vs. 3.3%; p = 0.039), with nonsignificant trend toward fewer bacteria (21.3 vs. 29.2%; p = 0.063). Escherichia coli species were most common in both populations.

Conclusions

Stool PCR identified numerous pathogens in patients with or without celiac disease/inflammatory bowel disease. Patients with celiac disease/inflammatory bowel disease were significantly less likely to have any pathogen identified, and had significantly fewer viruses and parasites. In this population, knowledge of common pathogens can guide diagnostic evaluation and offer opportunities for treatment.
Literatur
1.
Zurück zum Zitat Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007;62:23–28.CrossRefPubMedPubMedCentral Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007;62:23–28.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based swedish cohort. Arch Intern Med. 2003;163:1566–1572.CrossRefPubMed Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based swedish cohort. Arch Intern Med. 2003;163:1566–1572.CrossRefPubMed
3.
Zurück zum Zitat Thomas HJ, Wotton CJ, Yeates D, Ahmad T, Jewell DP, Goldacre MJ. Pneumococcal infection in patients with coeliac disease. Eur J Gastroenterol Hepatol. 2008;20:624–628.CrossRefPubMed Thomas HJ, Wotton CJ, Yeates D, Ahmad T, Jewell DP, Goldacre MJ. Pneumococcal infection in patients with coeliac disease. Eur J Gastroenterol Hepatol. 2008;20:624–628.CrossRefPubMed
4.
Zurück zum Zitat Marild K, Fredlund H, Ludvigsson JF. Increased risk of hospital admission for influenza in patients with celiac disease: a nationwide cohort study in Sweden. Am J Gastroenterol. 2010;105:2465–2473.CrossRefPubMed Marild K, Fredlund H, Ludvigsson JF. Increased risk of hospital admission for influenza in patients with celiac disease: a nationwide cohort study in Sweden. Am J Gastroenterol. 2010;105:2465–2473.CrossRefPubMed
5.
Zurück zum Zitat Lawson PA, Citron DM, Tyrrell KL, Finegold SM. Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prevot 1938. Anaerobe. 2016;40:95–99.CrossRefPubMed Lawson PA, Citron DM, Tyrrell KL, Finegold SM. Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prevot 1938. Anaerobe. 2016;40:95–99.CrossRefPubMed
6.
Zurück zum Zitat Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443–1450.CrossRefPubMed Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443–1450.CrossRefPubMed
7.
Zurück zum Zitat Saidel-Odes L, Borer A, Odes S. Clostridium difficile infection in patients with inflammatory bowel disease. Ann Gastroenterol. 2011;24:263–270.PubMedPubMedCentral Saidel-Odes L, Borer A, Odes S. Clostridium difficile infection in patients with inflammatory bowel disease. Ann Gastroenterol. 2011;24:263–270.PubMedPubMedCentral
8.
Zurück zum Zitat Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A. The impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr. 2009;154:854–858.CrossRefPubMed Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A. The impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr. 2009;154:854–858.CrossRefPubMed
9.
Zurück zum Zitat Khare R, Espy MJ, Cebelinski E, et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol. 2014;52:3667–3673.CrossRefPubMedPubMedCentral Khare R, Espy MJ, Cebelinski E, et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol. 2014;52:3667–3673.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Buss SN, Leber A, Chapin K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol. 2015;53:915–925.CrossRefPubMedPubMedCentral Buss SN, Leber A, Chapin K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol. 2015;53:915–925.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205–210.CrossRefPubMed Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205–210.CrossRefPubMed
12.
Zurück zum Zitat Lebwohl B, Nobel YR, Green PHR, Blaser MJ, Ludvigsson JF. Risk of Clostridium difficile infection in patients with celiac disease: a population-based study. Am J Gastroenterol. 2017;112:1878–1884.CrossRefPubMed Lebwohl B, Nobel YR, Green PHR, Blaser MJ, Ludvigsson JF. Risk of Clostridium difficile infection in patients with celiac disease: a population-based study. Am J Gastroenterol. 2017;112:1878–1884.CrossRefPubMed
13.
Zurück zum Zitat Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol. 2006;4:315–319.CrossRefPubMed Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol. 2006;4:315–319.CrossRefPubMed
14.
Zurück zum Zitat Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol. 2007;179:4704–4710.CrossRefPubMed Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol. 2007;179:4704–4710.CrossRefPubMed
15.
Zurück zum Zitat Jarry A, Malard F, Bou-Hanna C, et al. Interferon-alpha promotes Th1 response and epithelial apoptosis via inflammasome activation in human intestinal mucosa. Cell Mol Gastroenterol Hepatol. 2016;3:72–81.CrossRefPubMedPubMedCentral Jarry A, Malard F, Bou-Hanna C, et al. Interferon-alpha promotes Th1 response and epithelial apoptosis via inflammasome activation in human intestinal mucosa. Cell Mol Gastroenterol Hepatol. 2016;3:72–81.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Park SD, Markowitz J, Pettei M, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. Pediatr Gastroenterol Nutr.. 2007;44:431–435.CrossRef Park SD, Markowitz J, Pettei M, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. Pediatr Gastroenterol Nutr.. 2007;44:431–435.CrossRef
17.
Zurück zum Zitat Nemes É, Lefler É, Szegedi L, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008;121:e1570–e1576.CrossRefPubMed Nemes É, Lefler É, Szegedi L, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008;121:e1570–e1576.CrossRefPubMed
18.
Zurück zum Zitat Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol. 2003;98:2289–2292.CrossRefPubMed Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol. 2003;98:2289–2292.CrossRefPubMed
19.
Zurück zum Zitat Di Sabatino A, Rosado MM, Cazzola P, et al. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin Gastroenterol Hepatol. 2006;4:179–186.CrossRefPubMed Di Sabatino A, Rosado MM, Cazzola P, et al. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin Gastroenterol Hepatol. 2006;4:179–186.CrossRefPubMed
20.
Zurück zum Zitat Girbovan A, Sur G, Samasca G, Lupan I. Dysbiosis a risk factor for celiac disease. Med Microbiol Immunol. 2017;206:83–91.CrossRefPubMed Girbovan A, Sur G, Samasca G, Lupan I. Dysbiosis a risk factor for celiac disease. Med Microbiol Immunol. 2017;206:83–91.CrossRefPubMed
21.
Zurück zum Zitat Wlodarska M, Kostic AD, Xavier RJ. An integrative view of microbiome-host interactions in inflammatory bowel disease. Cell Host Microbe. 2015;17:577–591.CrossRefPubMedPubMedCentral Wlodarska M, Kostic AD, Xavier RJ. An integrative view of microbiome-host interactions in inflammatory bowel disease. Cell Host Microbe. 2015;17:577–591.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Fyderek K, Strus M, Kowalsa-Duplaga K, et al. Mucosal bacterial microflora and mucus later thickness in adolescents with inflammatory bowel disease. World J Gastroenterol. 2009;15:5287–5294.CrossRefPubMedPubMedCentral Fyderek K, Strus M, Kowalsa-Duplaga K, et al. Mucosal bacterial microflora and mucus later thickness in adolescents with inflammatory bowel disease. World J Gastroenterol. 2009;15:5287–5294.CrossRefPubMedPubMedCentral
Metadaten
Titel
Stool PCR for Gastrointestinal Pathogens in Patients With and Without Immune-Mediated Intestinal Diseases
verfasst von
Yael R. Nobel
Jordan Axelrad
Suzanne K. Lewis
Susan Whittier
Garrett Lawlor
Simon Lichtiger
Peter H. R. Green
Benjamin Lebwohl
Publikationsdatum
06.02.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-4959-x

Weitere Artikel der Ausgabe 4/2018

Digestive Diseases and Sciences 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.